ORASIS
ActiveSummary
ORASIS has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €146,860 and a net result of €56,215. Equity is growing by ~53.9% per year across the filed fiscal years. Its solvency ranks better than 24% of 19923 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability86▲+10
Solvency61▲+14
Growth78=
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12,000 at 30 days acceptable
Liquidity ample (current ratio 3.62 against 3.08 in 2023; short-term debt: 14.9% and cash: 35.6% of total assets), but 64.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 19923 sector peers (2024).
NBB · sector comparisonPosition among 19923 sector peers
Solvency
better than 24%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 5 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
14 d late
2022
53 d late
2021
99 d late
2020
75 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 60 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€56,215▲ 144%
2023 · €23,014
Working capital
€160,224▲ 58.3%
2023 · €101,246
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€16,264-€25,996▲ 59.8%€38,423▲ 47.8%€35,584▼ 7.4%€78,161▲ 120%
Net result€10,398within the sector's middle half-€15,873within the sector's middle half▲ 52.7%€26,361within the sector's middle half▲ 66.1%€23,014within the sector's middle half▼ 12.7%€56,215within the sector's middle half▲ 144%
Equity€25,398below the sector's middle half-€41,271below the sector's middle half▲ 62.5%€67,632below the sector's middle half▲ 63.9%€90,646within the sector's middle half▲ 34.0%€146,860within the sector's middle half▲ 62.0%
Total assets€560,941within the sector's middle half-€525,463within the sector's middle half▼ 6.3%€469,574within the sector's middle half▼ 10.6%€403,332within the sector's middle half▼ 14.1%€410,783within the sector's middle half▲ 1.8%
Debt€535,543-€484,192▼ 9.6%€401,942▼ 17.0%€312,686▼ 22.2%€263,922▼ 15.6%
Working capital€62,240within the sector's middle half-€145,651within the sector's middle half▲ 134%€79,551within the sector's middle half▼ 45.4%€101,246within the sector's middle half▲ 27.3%€160,224within the sector's middle half▲ 58.3%
Solvency4.5%below the sector's middle half-7.9%below the sector's middle half▲ 3.3pp14.4%below the sector's middle half▲ 6.5pp22.5%below the sector's middle half▲ 8.1pp35.8%below the sector's middle half▲ 13.3pp
Current ratio1.93within the sector's middle half-8.46above the sector's middle half▲ 6.542.31within the sector's middle half▼ 6.153.08within the sector's middle half▲ 0.763.62within the sector's middle half▲ 0.55
Return on assets (ROA)1.9%within the sector's middle half-3.0%within the sector's middle half▲ 1.2pp5.6%within the sector's middle half▲ 2.6pp5.7%within the sector's middle half▲ 0.1pp13.7%within the sector's middle half▲ 8.0pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 120% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €410,783
Fixed assets
€189,488 ▼ 25.2%
Current assets
€221,294 ▲ 47.5%
Equity and liabilities €410,783
Equity
€146,860 ▲ 62.0%
Debt
€263,922 ▼ 15.6%
Debt's share of the balance-sheet total falls from 77.5% to 64.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€145,935▲
2023 · €120,458
Cash flow
€123,989▲
2023 · €107,888
Debt to equity
1.80▼
2023 · 3.45
ROE
38.3%▲
2023 · 25.4%
Interest coverage
72.76▲
2023 · 43.49
Debt ≤ 1 year
€61,070▲
2023 · €48,769
Debt > 1 year
€200,983▼
2023 · €263,917
Income taxes
€20,157▲
2023 · €9,800
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,970 companies that looked in July 2024 the way this one looks now, 1.5% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.5%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.3% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,970 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Goods, raw materials, services and sundry goods60/61 | - | €239,039 | - | - | - | - |
| Remuneration, social security and pensions62 | - | €1,258 | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €112,763 | €74,681 | €81,966 | €84,874 | €67,774 | ▼ 20.1% |
| Other operating charges640/8 | - | €326 | €449 | €444 | €6,090 | ▲ 1,270% |
| Gross operating margin9900 | €129,881 | €102,261 | €120,839 | €120,902 | €152,025 | ▲ 25.7% |
| Operating profit (loss)9901 | €16,264 | €25,996 | €38,423 | €35,584 | €78,161 | ▲ 120% |
| Financial income75/76B | - | - | - | €0 | €216 | ▲ 539,650% |
| Recurring financial income75 | - | - | - | €0 | €216 | ▲ 539,650% |
| Financial charges65/66B | - | €4,216 | €1,619 | €2,770 | €2,006 | ▼ 27.6% |
| Recurring financial charges65 | €1,866 | €4,216 | €1,619 | €2,770 | €2,006 | ▼ 27.6% |
| Profit (loss) for the period before taxes9903 | €14,398 | €21,780 | €36,804 | €32,814 | €76,371 | ▲ 133% |
| Income taxes67/77 | €4,000 | €5,907 | €10,443 | €9,800 | €20,157 | ▲ 106% |
| Profit (loss) for the period9904 | €10,398 | €15,873 | €26,361 | €23,014 | €56,215 | ▲ 144% |
| Profit (loss) for the period to be appropriated9905 | €10,398 | €15,873 | €26,361 | €23,014 | €56,215 | ▲ 144% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €560,941 | €525,463 | €469,574 | €403,332 | €410,783 | ▲ 1.8% |
| Fixed assets21/28 | €431,632 | €360,299 | €329,387 | €253,316 | €189,488 | ▼ 25.2% |
| Intangible fixed assets21 | €320,309 | €282,619 | €244,930 | €207,240 | €169,551 | ▼ 18.2% |
| Tangible fixed assets22/27 | €111,323 | €77,680 | €84,458 | €46,076 | €19,937 | ▼ 56.7% |
| Plant, machinery and equipment23 | - | €816 | €490 | €163 | €3,588 | ▲ 2,103% |
| Furniture and vehicles24 | - | €75,996 | €78,065 | €38,034 | €11,220 | ▼ 70.5% |
| Other tangible fixed assets26 | - | €868 | €5,903 | €7,879 | €5,129 | ▼ 34.9% |
| Current assets29/58 | €129,309 | €165,164 | €140,187 | €150,016 | €221,294 | ▲ 47.5% |
| Amounts receivable within one year40/41 | €39,379 | €26,530 | €55,685 | €50,807 | €73,981 | ▲ 45.6% |
| Trade receivables40 | - | €26,530 | €55,685 | €50,607 | €73,814 | ▲ 45.9% |
| Other amounts receivable41 | - | - | - | €200 | €167 | ▼ 16.6% |
| Cash at bank and in hand54/58 | €89,930 | €138,634 | €84,502 | €99,209 | €146,034 | ▲ 47.2% |
| Deferred charges and accrued income490/1 | - | - | - | - | €1,279 | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €560,941 | €525,463 | €469,574 | €403,332 | €410,783 | ▲ 1.8% |
| Equity10/15 | €25,398 | €41,271 | €67,632 | €90,646 | €146,860 | ▲ 62.0% |
| Contributions10/11 | - | €15,000 | €15,000 | €15,000 | €15,000 | = |
| Outside capital11 | - | - | €15,000 | €15,000 | - | - |
| Other1109/19 | - | - | €15,000 | €15,000 | - | - |
| Reserves13 | - | €15,000 | €38,800 | €61,800 | €101,800 | ▲ 64.7% |
| Distributable reserves133 | - | €15,000 | €38,800 | €61,800 | €101,800 | ▲ 64.7% |
| Profit (loss) carried forward14 | €10,398 | €11,271 | €13,832 | €13,846 | €30,060 | ▲ 117% |
| Amounts payable17/49 | €535,543 | €484,192 | €401,942 | €312,686 | €263,922 | ▼ 15.6% |
| Amounts payable after more than one year17 | €468,474 | €464,679 | €341,307 | €263,917 | €200,983 | ▼ 23.8% |
| Financial debts170/4 | - | €285,652 | €199,917 | €164,131 | €131,070 | ▼ 20.1% |
| Other amounts payable178/9 | - | €179,027 | €141,390 | €99,785 | €69,913 | ▼ 29.9% |
| Amounts payable within one year42/48 | €67,069 | €19,513 | €60,636 | €48,769 | €61,070 | ▲ 25.2% |
| Financial debts43 | - | €3,953 | €46,147 | €38,961 | €36,665 | ▼ 5.9% |
| Credit institutions430/8 | - | €3,953 | €46,147 | €38,961 | €36,665 | ▼ 5.9% |
| Trade debts44 | €2,883 | €961 | €7,497 | €2,809 | €908 | ▼ 67.7% |
| Suppliers440/4 | - | €961 | €7,497 | €2,809 | €908 | ▼ 67.7% |
| Taxes, remuneration and social security45 | - | €14,599 | €6,992 | €7,000 | €23,498 | ▲ 236% |
| Taxes450/3 | - | €6,000 | - | €7,000 | €19,000 | ▲ 171% |
| Remuneration and social security454/9 | - | €8,599 | €6,992 | - | €4,498 | - |
| Accrued charges and deferred income492/3 | - | - | - | - | €1,869 | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €10,398 | €15,873 | €26,361 | €23,014 | €56,215 | ▲ 144% |
| + Depreciation and write-downs630 | €112,763 | €74,681 | €81,966 | €84,874 | €67,774 | ▼ 20.1% |
| Operating cash flow (approximation) | €123,161 | €90,554 | €108,327 | €107,888 | €123,989 | ▲ 14.9% |
| Investment in fixed assets (approximation) | - | -€3,349 | -€51,055 | -€8,803 | -€3,946 | ▲ 55.2% |
| Change in cash | - | €48,703 | -€54,132 | €14,707 | €46,826 | ▲ 218% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
31-12
Financial
Highest result since 2020net €56,215 ▲144%
Operating result €78,161, net result €56,215, both a record.
31-12
Financial
Equity above €100,000Eq €146,860 ▲62%
5 profitable years in a row build equity to €146,860.
14-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 14 days late
2023
22-09
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 53 days late
2022
07-11
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 99 days late
2021
31-12
Financial
Liquidity quadruplescurrent ratio 8.46
Current ratio from 1.93 to 8.46; short-term debt falls from €67,069 to €19,513.
14-10
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 75 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Etterbeek · 1 establishment unit since 2019
Ground area
124 m²
Building footprint
93 m²
Volume, LiDAR
990 m³
Parcel 21362B0057/00S010, Brussels · tallest building 14.6 m, ±4 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
ORASIS
since 20192.300.988.468
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21362B0057/00S010 | Brussels | 124 m² | 1 · 93 m² | 14.6 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
LVHK
BE 0797.263.784
Liège · Eq €146,859
Dokter Veronique Demeulemeester
BE 0711.896.064
Aartselaar · Eq €146,837
Dr. A.S. Bonte
BE 1019.215.424
Antwerpen · Eq €146,800
Dr BARO.J
BE 0687.620.924
Lasne · Eq €146,797
DR. D. OSTIJN
BE 0480.011.527
Gent · Eq €146,952
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 6,737 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded01-07-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0729621528
Registered
20-08-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.